Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 01-2006 | 10-2005 | 07-2005 | 04-2005 | 01-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 809 | 507 | 582 | 641 | 1,012 |
| Marketable Securities | 403 | 401 | 398 | 396 | N/A |
| Receivables | 30 | 32 | 173 | 99 | 288 |
| Inventories | 330 | 385 | 555 | 877 | 977 |
| TOTAL | $1,611 | $1,404 | $1,720 | $2,029 | $2,305 |
| Non-Current Assets | |||||
| PPE Net | 31 | 27 | 30 | 33 | 37 |
| Other Non-Current Assets | 5 | 35 | 5 | 6 | 6 |
| TOTAL | $36 | $62 | $35 | $39 | $42 |
| Total Assets | $1,646 | $1,466 | $1,756 | $2,068 | $2,347 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 404 | 271 | 232 | 252 | 398 |
| Accrued Expenses | 68 | 77 | 39 | 41 | 24 |
| TOTAL | $472 | $348 | $270 | $293 | $422 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $472 | $348 | $270 | $293 | $422 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,765 | 3,750 | 3,629 | 3,554 | 3,483 |
| Common Shares | 938 | 920 | 905 | 885 | 869 |
| Retained earnings | -74,147 | -72,908 | -71,762 | -70,643 | -69,463 |
| TOTAL | $1,174 | $1,118 | $1,486 | $1,775 | $1,925 |
| Total Liabilities And Equity | $1,646 | $1,466 | $1,756 | $2,068 | $2,347 |